Belgium· BE-AMP-SAM322743-00

Janumet 50 mg - 1000 mg

A metformin and sitagliptin product containing sitagliptin phosphate monohydrate, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 14 of our 19 countries.

ATC A10BD07

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about sitagliptin phosphate monohydrateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and sitagliptin is registered in 14 of 19 countries.

Countries holding a registration under ATC A10BD07 (metformin and sitagliptin), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
9 of them publish a price we can compare per daily dose

Search metformin and sitagliptin products by name

Metformin and sitagliptin · ATC A10BD07

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Sitagliptin Phosphate Monohydrate
Manufacturer: Merck Sharp & Dohme
Country: Belgium (BE)
ATC code: A10BD07
ATC class: Metformin and sitagliptin
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 5

3 priced

be_apb
0797837
be_apb
7728215
be_apb
2572121
EUR 24.61
be_apb
2572139
EUR 66.6
be_apb
4165718
EUR 43.33

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for metformin and sitagliptin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check metformin and sitagliptin against other medicines How interaction checks work

Metformin and sitagliptin · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and sitagliptin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and sitagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Jansitin, Jazeta
Bulgaria · Sitagliptin Grindeks, Майсиглу
Cyprus · Jidinum, Jimandin
Czechia · Anau, Ansifora
Germany · Frekidir, Jansitin
Denmark · Frekidir, Meliglix
Estonia · Adimuplan, Maysiglu
Spain · Altuxerin, Disit
Finland · Sitagliptin Apc Instytut, Sitagliptin Ashcure
France · Sitagliptine Adamed, Sitagliptine Almus
United Kingdom (Northern Ireland) · Sitagliptin, Sitagliptin Amarox
Greece · Adimuplan, Axavel
Croatia · Adimuplan, Condias
Hungary · Ansifora, Jaglix
Ireland · Sitagliptin Grindeks, Sitagliptin Krka
Iceland · Januvia, Ristaben
Italy · Adaglip, Andamane
Liechtenstein · Januvia, Ristaben
Lithuania · Adimuplan, Jimandin
Luxembourg · Sitagliptin Eg
Latvia · Adimuplan, Jimandin
Malta · Anau, Jidinum
Netherlands · Adimuplan, Anau
Norway · Frekidir, Januvia
Poland · Ansifora, Jansitin
Portugal · Itam, Jidinum
Romania · Adimuplan, Jansitin
Sweden · Axavel, Frekidir
Slovenia · Adimuplan, Maysiglu
Slovakia · Adimuplan, Anau

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/86b512f1-2664-457b-aec0-9c85bf24a30b
GET /v1/drugs/86b512f1-2664-457b-aec0-9c85bf24a30b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Janumet 50 mg - 1000 mg",
  "name_fr": "Janumet 50 mg - 1000 mg",
  "name_nl": "Janumet 50 mg - 1000 mg",
  "amp_code": "SAM322743-00",
  "strengths": [
    "1000.0000",
    "50.0000",
    "50.0000",
    "1000.0000",
    "50.0000"
  ],
  "pack_count": 12,
  "substances": [
    "Sitagliptin Phosphate Monohydrate",
    "Metformin Hydrochloride",
    "Sitagliptin",
    "Sodium Laurilsulfate",
    "Sodium Stearyl Fumarate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Metformin and Sitagliptin",
  "authorisation_numbers": [
    "EU/1/08/455/008",
    "EU/1/08/455/009",
    "EU/1/08/455/010",
    "EU/1/08/455/011",
    "EU/1/08/455/012",
    "EU/1/08/455/013",
    "EU/1/08/455/014",
    "EU/1/08/455/016",
    "EU/1/08/455/018",
    "EU/1/08/455/022",
    "EU/1/08/455/021"
  ]
}

API reference MCP server Plans

See everything about metformin and sitagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console